Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-23

FDA Approved: FOMEPIZOLE — Supplemental Application (Navinta LLC)

View source ↗

Summary

FDA approved a supplemental application for fomepizole from Navinta LLC, providing a generic form of the antidote used to treat methanol and ethylene glycol poi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fomepizole (generic) (Fomepizole)

Snippet

SUPPL AP for FOMEPIZOLE (FOMEPIZOLE)